DIVI'S LAB: TP 830,900

Subsequent to steep fall( 1385 in Sep16), Divi looks set for a bounce back.

Q3 is better despite  *income tax provision@ 27% vs 20%*

Sales 976cr vs 860cr YoY

EBIDTA margin 39% vs 37.6%

PBT 368cr vs 307cr, *up20%*

PAT 268cr vs 246cr, up 9%

Q3 tax provision 100cr vs 61cr

For 9 month, PAT 794cr vs 789 cr _despite one time provision of 79 cr towards exgratia payment_

Divi had already filed reply to FDA observations

Looking at high of 1385 in Sept 2016,  stock can bounce back to 900